DENISE SHOOK: Open Payments
NPI 1891492450 · MILAN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,415 in 41 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $387 · 2025 $1,415
Food & beverage: $924Long term medical supply or device loan: $299Education: $192
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $299 |
| Janssen Biotech, Inc. | 5 | $184 |
| BeOne Medicines USA, Inc. | 1 | $150 |
| Astellas Pharma US Inc | 1 | $92 |
| Daiichi Sankyo Inc. | 3 | $84 |
| E.R. Squibb & Sons, L.L.C. | 4 | $67 |
| Lilly USA, LLC | 3 | $66 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| Aveo Pharmaceuticals, Inc. | 2 | $59 |
| Amgen Inc. | 1 | $48 |
Products named: KISQALI, BRUKINSA, ERLEADA, Enhertu, VERZENIO, FOTIVDA, TECVAYLI, IMDELLTRA (AMG757).
Industry payments across TN — which companies pay providers there.
